Takeda President-To-Be Weber To Face Shareholder Opposition At Meeting
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical's British president-in-waiting, Christophe Weber, faces opposition to his appointment by shareholders as well as a former management team and some members of the founding family.